Dr. Gali Artzi is Partner and CTO at PeakBridge, a $260M venture capital firm investing across food, nutrition and health, with 36+ portfolio companies from seed to Series B. She holds a PhD in immunology and spent 15 years leading R&D, innovation, and commercialization at global ingredient companies, taking products from lab to market. She has worked on transactions from both sides of the table, including large-scale M&A and an IPO, and sits on several PeakBridge portfolio company boards. For more information visit https://peakbridge.vc/.